文献速递前列腺增生与排尿功能障碍

赋能患者选择:良性前列腺增生决策辅助工具的系统综述

Empowering patient choice: a systematic review of decision aids for benign prostatic hyperplasia.
PubMed 文献 · BJU Int · 2025-05-27

该系统综述检索8个数据库共1979条结果,纳入13项国际研究、涉及10种决策辅助工具,评估症状性良性前列腺增生男性可用的决策干预。多数工具侧重治疗信息提供,风险信息呈现不均衡,且缺乏行为改变理论与临床持续实施的明确联系;最有效的工具采用多种行为改变技术以引出并整合患者偏好与价值观。

要点

  • 多数BPH决策辅助工具侧重治疗信息,风险信息呈现不总是均衡
  • 最有效工具采用多种行为改变技术引出并整合患者偏好与价值观
  • 现有工具缺乏与行为改变、风险沟通和决策理论的明确联系

核心结论

  • 当前BPH相关决策辅助工具缺乏对个体患者需求的明确关注,不足以为以患者为中心的照护提供支持。
  • 需要提高透明度,并与行为理论及行为改变技术建立与未来结局、期望和价值观相关的明确联系,才能有效创建并实施干预。

研究设计与样本

  • 系统综述,检索PubMed、Web of Science、EBSCO、Science Direct、Scopus、Google、Cochrane Library、Centre for Reviews and Dissemination共8个数据库。
  • 共检索到1979条结果,最终纳入13项国际研究,涉及10种决策辅助工具。
  • 纳入标准为针对有泌尿系统症状的成年男性、讨论旨在促进二级医疗中共享决策的决策辅助工具的研究。

主要发现

  • 叙述性综合发现多数决策辅助工具侧重治疗信息提供,但风险信息并非总是同等呈现。
  • 多数工具缺乏与现有行为改变、风险沟通和决策理论的强理论联系,也缺乏在临床实践中的持续实施。
  • 最有效的工具超越信息提供,通过采用多种行为改变技术引出并整合患者偏好与价值观。
  • 偏倚风险评估显示为中等风险,数据收集和分析方法的细节或依据有限。

临床怎么用

  • 选择或开发BPH决策辅助工具时,应优先纳入能引出并整合患者偏好与价值观的多技术干预。
  • 工具应明确关联行为改变理论与行为改变技术,并考虑临床实践中的持续实施。
  • 需注意现有工具风险信息呈现不均衡,使用时应补充均衡的风险沟通。

局限性

  • 偏倚风险评估为中等风险,纳入研究在数据收集和分析方法上信息或依据有限。
  • 检索范围限于二级医疗场景中促进共享决策的决策辅助工具,未涵盖其他场景。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Benign prostatic hyperplasia (BPH) is a complex condition that affects ~3.2 million men in the UK. As men often face multiple treatment options, discussion and consideration of their priorities and preferences is necessary; however, research indicates this is not always adopted in practice. OBJECTIVES: To evaluate decisional interventions currently available for men with symptomatic BPH, distinct from those designed for prostate cancer. METHODS: Eight databases (PubMed, Web of Science, EBSCO, Science Direct, Scopus, Google, Cochrane Library, Centre for Reviews and Dissemination) were searched retrieving a total of 1979 results, of which 13 international studies discussing 10 decision aids (DAs) were included. Studies were eligible that targeted adult males experiencing urological symptoms and discussed any DA designed to promote shared decision making within secondary healthcare. RESULTS: Narrative synthesis found most DAs focused on treatment information provision; however, risk information was not always equally presented. Most DAs lacked strong theoretical links to existing theories on behaviour change, risk communication, and decision making, and sustained implementation within clinical practice. The most effective aids went beyond information provision, to also elicit and integrate patient preferences and values, by adopting multiple behaviour change techniques (BCTs). Risk of bias indicated medium risk with limited information or justification on data collection and analysis methods. CONCLUSION: Current DAs relevant to BPH lack clear focus on individual patient needs required for delivering patient-centred care. Greater transparency and explicit links to behavioural theory and BCTs related to desired future outcomes, expectations, and values are required to effectively create and implement effective interventions into urological practice.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Hollands C, Gray D, Marren A, et al. Empowering patient choice: a systematic review of decision aids for benign prostatic hyperplasia. BJU Int. 2025. PMID: 40420675. doi:10.1111/bju.16797

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。